Latham & Watkins represented the underwriters in the offering.Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, executed an…
Cogent Biosciences’ $150 Million Upsized Shares Offering and Pre-funded Warrants
